Pregabalin: in the treatment of postherpetic neuralgia.

@article{McKeage2009PregabalinIT,
  title={Pregabalin: in the treatment of postherpetic neuralgia.},
  author={Kate McKeage and Susan J. Keam},
  journal={Drugs & aging},
  year={2009},
  volume={26 10},
  pages={
          883-92
        }
}
  • Kate McKeage, Susan J. Keam
  • Published 2009
  • Medicine
  • Drugs & aging
  • Pregabalin is the pharmacologically active S-enantiomer of 3-aminomethyl-5-methyl-hexanoic acid. It has a similar pharmacological profile to that of its developmental predecessor gabapentin, but had greater analgesic activity in rodent models of neuropathic pain. Pregabalin is thought to act by reducing the excessive release of several excitatory neurotransmitters by binding to the alpha(2)-delta protein subunit of voltage-gated calcium channels. Oral pregabalin 150-600 mg/day, administered in… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 46 CITATIONS, ESTIMATED 56% COVERAGE

    Pregabalin as a Pain Therapeutic: Beyond Calcium Channels

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2007
    2020

    CITATION STATISTICS

    • 3 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 45 REFERENCES

    Pregabalin: a new anxiolytic